Billing and Coding: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease

This billing/coding guidance applies to the Prostate Cancer Genomic Classifier assay for men with localized prostate cancer (ICD-10-CM C61). Claims must include the applicable CPT code, report 1 unit of service, and include the appropriate DEX Z-Code adjacent to the CPT code in specified Part A and Part B claim fields (Loop 2400/SV101-7 or Item 19 for Part B; SV202-7 or Block 80 for Part A).

"Prostate Genomic Classifier assay is for men with localized prostate cancer (report with diagnosis code ICD-10-CM C61)."

Sign up to see full coverage criteria, indications, and limitations.